Deletion of IL-17ra in osteoclast precursors increases bone mass by decreasing osteoclast precursor abundance
Abstract
No abstract availableKeywords
Funding Information
- Health Services Research and Development
- NIH (R01 AG064464)
- US Department of Veterans Affairs (I01BX004708)
- Emory University
This publication has 38 references indexed in Scilit:
- Estrogen Deficiency Induces the Differentiation of IL-17 Secreting Th17 Cells: A New Candidate in the Pathogenesis of OsteoporosisPLOS ONE, 2012
- Runx1 dose-dependently regulates endochondral ossification during skeletal development and fracture healingJournal of Bone and Mineral Research, 2012
- Potentiation of Th17 cytokines in aging process contributes to the development of colitisCellular Immunology, 2011
- Inflammation and Uncoupling as Mechanisms of Periodontal Bone LossJournal of Dental Research, 2010
- IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cellsBiochimie, 2010
- Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursorsArthritis Research & Therapy, 2010
- A bone‐protective role for IL‐17 receptor signaling in ovariectomy‐induced bone lossEuropean Journal of Immunology, 2009
- An overview of IL-17 function and signalingCytokine, 2008
- Aging Increases Stromal/Osteoblastic Cell-Induced Osteoclastogenesis and Alters the Osteoclast Precursor Pool in the MouseJournal of Bone and Mineral Research, 2005
- TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligandJournal of Clinical Investigation, 2000